0001140361-17-007278.txt : 20170214 0001140361-17-007278.hdr.sgml : 20170214 20170214161845 ACCESSION NUMBER: 0001140361-17-007278 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20161231 FILED AS OF DATE: 20170214 DATE AS OF CHANGE: 20170214 EFFECTIVENESS DATE: 20170214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sarissa Capital Management LP CENTRAL INDEX KEY: 0001577524 IRS NUMBER: 900924432 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-15935 FILM NUMBER: 17609169 BUSINESS ADDRESS: STREET 1: 660 STEAMBOAT ROAD CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 203-302-2330 MAIL ADDRESS: STREET 1: 660 STEAMBOAT ROAD CITY: GREENWICH STATE: CT ZIP: 06830 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001577524 XXXXXXXX 12-31-2016 12-31-2016 Sarissa Capital Management LP
660 STEAMBOAT ROAD GREENWICH CT 06830
13F HOLDINGS REPORT 028-15935 N
Alexander J. Denner, Ph.D. Chief Investment Officer 203-302-2330 /s/ Alexander J. Denner Greenwich CT 02-14-2017 0 11 363082 false
INFORMATION TABLE 2 form13fInfoTable.xml ABBVIE INC. COM 00287Y109 626 10000 SH SOLE 10000 0 0 ADVAXIS INC COM NEW 007624208 3579 500000 SH SOLE 500000 0 0 APRICUS BIOSCIENCES INC COM NEW 03832V307 1882 1447906 SH SOLE 1447906 0 0 ARIAD PHARMACEUTICALS INC COM 04033A100 159853 12850000 SH SOLE 12850000 0 0 AVEO PHARMACEUTICALS INC COM 053588109 917 1700000 SH SOLE 1700000 0 0 BIOGEN INC COM 09062X103 87909 310000 SH SOLE 310000 0 0 INNOVIVA INC COM 45781M101 31832 2975000 SH SOLE 2975000 0 0 INTRA CELLULAR THERAPIES INC COM 46116X101 5432 360000 SH SOLE 360000 0 0 MEDICINES CO COM 584688105 59462 1752000 SH SOLE 1752000 0 0 NOVELION THERAPEUTICS INC COM NEW 67001K202 8630 1025000 SH SOLE 1025000 0 0 VIVUS INC COM 928551100 2960 2573943 SH SOLE 2573943 0 0